Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors
1 other identifier
observational
425
1 country
1
Brief Summary
Women often face common cancers like ovarian, uterine, and cervical cancers. Improvements in cancer detection and treatment mean more women survive. However, survivors can encounter challenges like ongoing pain, treatment complications, and fertility issues. Treating these cancers often involves surgeries that might include removing ovaries or using pelvic radiation. This can trigger menopause in younger women, causing problems like vaginal dryness, itching, and urinary issues. Women who've gone through menopause often deal with these symptoms, affecting their daily lives, confidence, and intimate relationships. Though treatments are available, lack of awareness, embarrassment, and not discussing these issues with doctors can make managing them difficult. The main treatment for these symptoms is using vaginal estrogen, but it might not be suitable for some cancer survivors. Non-hormonal options like lubricants and moisturizers are alternatives. This study in Thailand aiming to explore how common these issues are among gynecological cancer survivors, their feelings about it, and how it affects their quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2024
CompletedFirst Posted
Study publicly available on registry
March 12, 2024
CompletedStudy Start
First participant enrolled
March 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedApril 25, 2024
April 1, 2024
9 months
March 3, 2024
April 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of genitourinary syndrome of menopause
Prevalence of genitourinary syndrome of menopause among gynecologic cancer survivor (percent)
Baseline
Secondary Outcomes (3)
Severity of genitourinary syndrome of menopause
Baseline
Quality of life of gynecologic cancer survivor
Baseline
Attitude toward genitourinary syndrome of menopause in gynecologic cancer survivor
Baseline
Eligibility Criteria
Gynecologic cancer survivors, age more than 18 years old that came to the Gynecology Clinic at Khon Kaen University Hospital for routine cancer surveillance.
You may qualify if:
- Participant with gynecologic cancer (cancer of ovary, fallopian tube, uterus, cervix, vagina, and vulva.)
- Time passed more than 6 months since last cancer treatment.
You may not qualify if:
- Participant not entering menopause after cancer treatment.
- Participant with cancer progression.
- Participant currently suffer from severe pain, fatigue, or discomfort.
- Participant deny to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine, Khon Kaen University
Khon Kaen, 40002, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Apiwat Jongjakapun, MD
Khon Kaen University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 3, 2024
First Posted
March 12, 2024
Study Start
March 14, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
April 25, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share